Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
McKesson
Cantor Fitzgerald
McKinsey
Farmers Insurance
Daiichi Sankyo
Moodys
Cipla
Medtronic
AstraZeneca

Generated: December 11, 2017

DrugPatentWatch Database Preview

SOMA Drug Profile

« Back to Dashboard

When do Soma patents expire, and what generic alternatives are available?

Soma is a drug marketed by Mylan Speciality Lp, Meda Pharms, Ipsen Pharma, and Pharmacia And Upjohn. and is included in five NDAs. There are two patents protecting this drug.

The generic ingredient in SOMA is pegvisomant. One supplier is listed for this compound. Additional details are available on the pegvisomant profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Mylan Speciality LpSOMAcarisoprodolCAPSULE;ORAL011792-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ipsen PharmaSOMATULINE DEPOTlanreotide acetateSOLUTION;SUBCUTANEOUS022074-003Aug 30, 2007RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Pharmacia And UpjohnSOMAVERTpegvisomantINJECTABLE;SUBCUTANEOUS021106-004Jul 31, 2014RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Ipsen PharmaSOMATULINE DEPOTlanreotide acetateSOLUTION;SUBCUTANEOUS022074-001Aug 30, 2007RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Meda PharmsSOMA COMPOUNDaspirin; carisoprodolTABLET;ORAL012365-005Jul 11, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ipsen PharmaSOMATULINE DEPOTlanreotide acetateSOLUTION;SUBCUTANEOUS022074-002Aug 30, 2007RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Ipsen PharmaSOMATULINE DEPOTlanreotide acetateSOLUTION;SUBCUTANEOUS022074-003Aug 30, 2007RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Ipsen PharmaSOMATULINE DEPOTlanreotide acetateSOLUTION;SUBCUTANEOUS022074-001Aug 30, 2007RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Ipsen PharmaSOMATULINE DEPOTlanreotide acetateSOLUTION;SUBCUTANEOUS022074-003Aug 30, 2007RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Ipsen PharmaSOMATULINE DEPOTlanreotide acetateSOLUTION;SUBCUTANEOUS022074-003Aug 30, 2007RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Argus Health
Johnson and Johnson
Baxter
Novartis
Accenture
Daiichi Sankyo
Harvard Business School
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot